Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshio Imai

Showing results (181-190 of 196) with videos related to

Pageof 20
Sort By:
International Immunology|January 23, 2019
Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytesYoshikazu Kuboi, Miyuki Nishimura, Wataru Ikeda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2018
Role of Anti-Fractalkine Antibody in Suppression of Joint Destruction by Inhibiting Migration of Osteoclast Precursors to the Synovium in Experimental ArthritisKana Hoshino-Negishi, Masayoshi Ohkuro, Tomoya Nakatani, et al.
Transplantation|June 24, 2022
Novel Complement C5 Small-interfering RNA Lipid Nanoparticle Prolongs Graft Survival in a Hypersensitized Rat Kidney Transplant ModelHidetoshi Ishigooka, Haruki Katsumata, Kan Saiga, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 8, 2019
Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX<sub>3</sub> CL1/CX<sub>3</sub> CR1 Pathway in Experimental Mouse Models of Systemic SclerosisVu H Luong, Akira Utsunomiya, Takenao Chino, et al.
Toxicologic Pathology|April 17, 2003
Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic miceMasaya Takaoka, Shinya Sehata, Takanori Maejima, et al.
Particle and Fibre Toxicology|September 4, 2009
Genotoxicity of nano/microparticles in in vitro micronuclei, in vivo comet and mutation assay systemsYukari Totsuka, Takashi Higuchi, Toshio Imai, et al.
Human Pathology|October 24, 2025
Histological characteristics of primary biliary cholangitis in patients with incomplete responses to ursodeoxycholic acidKenichi Harada, Yuko Kakuda, Atsushi Tanaka, et al.
Journal of Translational Autoimmunity|April 14, 2025
A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitisAtsushi Tanaka, Masanori Abe, Tadashi Namisaki, et al.
Nature|January 25, 2019
GPR31-dependent dendrite protrusion of intestinal CX3CR1<sup>+</sup> cells by bacterial metabolitesNaoki Morita, Eiji Umemoto, Setsuko Fujita, et al.
Molecular Cancer Therapeutics|October 24, 2022
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic DrugsShuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata, et al.
Pageof 20

Showing results (181-190 of 196) with videos related to

Sort By:
Pageof 20
International Immunology|January 23, 2019
Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytesYoshikazu Kuboi, Miyuki Nishimura, Wataru Ikeda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2018
Role of Anti-Fractalkine Antibody in Suppression of Joint Destruction by Inhibiting Migration of Osteoclast Precursors to the Synovium in Experimental ArthritisKana Hoshino-Negishi, Masayoshi Ohkuro, Tomoya Nakatani, et al.
Transplantation|June 24, 2022
Novel Complement C5 Small-interfering RNA Lipid Nanoparticle Prolongs Graft Survival in a Hypersensitized Rat Kidney Transplant ModelHidetoshi Ishigooka, Haruki Katsumata, Kan Saiga, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 8, 2019
Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX<sub>3</sub> CL1/CX<sub>3</sub> CR1 Pathway in Experimental Mouse Models of Systemic SclerosisVu H Luong, Akira Utsunomiya, Takenao Chino, et al.
Toxicologic Pathology|April 17, 2003
Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic miceMasaya Takaoka, Shinya Sehata, Takanori Maejima, et al.
Particle and Fibre Toxicology|September 4, 2009
Genotoxicity of nano/microparticles in in vitro micronuclei, in vivo comet and mutation assay systemsYukari Totsuka, Takashi Higuchi, Toshio Imai, et al.
Human Pathology|October 24, 2025
Histological characteristics of primary biliary cholangitis in patients with incomplete responses to ursodeoxycholic acidKenichi Harada, Yuko Kakuda, Atsushi Tanaka, et al.
Journal of Translational Autoimmunity|April 14, 2025
A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitisAtsushi Tanaka, Masanori Abe, Tadashi Namisaki, et al.
Nature|January 25, 2019
GPR31-dependent dendrite protrusion of intestinal CX3CR1<sup>+</sup> cells by bacterial metabolitesNaoki Morita, Eiji Umemoto, Setsuko Fujita, et al.
Molecular Cancer Therapeutics|October 24, 2022
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic DrugsShuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata, et al.
Pageof 20